Toetal Solutions

Toetal Solutions

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Toetal Solutions is a US-based medical device innovator founded in 2013, specializing in the foot and ankle orthopedic sector. Its core technology is the ZipToe™ Hammertoe System, a nitinol-based implant designed with surgeon input for stability, compression, and ease of use in ASC settings. The company is in a pre-revenue, pre-FDA approval stage, having raised $2.82 million in recent financing to advance product development and regulatory pathways. Leadership combines experienced orthopedic industry veterans with practicing podiatric surgeons.

OrthopedicsPodiatry

Technology Platform

Surgeon-designed implant platform utilizing proprietary deployable nitinol technology for active compression and stability in foot and ankle bone fusion, specifically engineered for ambulatory surgical center (ASC) workflows.

Opportunities

The rapid shift of foot and ankle surgeries to ambulatory surgical centers (ASCs) creates a strong demand for efficient, purpose-built technologies like ZipToe™.
The large and consistent procedural volume for hammertoe correction provides a substantial initial addressable market for a differentiated implant system.

Risk Factors

The company faces significant regulatory risk as its lead product is not yet FDA-cleared.
As a pre-revenue company with limited capital, it also carries financial and commercialization risks, including the challenge of driving surgeon adoption in a competitive market post-approval.

Competitive Landscape

The hammertoe fixation market is competitive, with several established players offering implants using screws, pins, and other nitinol devices. Toetal's competition must differentiate on surgeon preference, clinical outcomes, cost-in-use, and specifically on its value proposition for ASC efficiency with its all-in-one disposable kit.